Non-stimulant ADHD meds can help adults manage attention difficulties, impulsivity, and problems with organization without using stimulant medication. They may be an option if stimulants cause unwanted side effects, have not helped enough, or are not a good fit because of other health factors.
Several medications are available, but they work differently and have different risks. Atomoxetine (Strattera) and viloxazine (Qelbree) are FDA-approved for ADHD in adults. Other medications, including bupropion and guanfacine, may be considered off-label in certain cases.
The right treatment depends on your symptoms, medical history, other medications, and how ADHD affects your daily life. Recognizing the signs of ADHD in adults and how the condition is diagnosed can help you prepare for a psychiatric evaluation and discuss your treatment options.
How Non-Stimulant ADHD Medication Works
Non-stimulant ADHD medication can help regulate brain processes involved in attention, impulse control, and executive functioning. Unlike stimulant medications, which often begin working on the day they are taken, non-stimulants may take several weeks to show their full benefits. When choosing medication and planning follow-up, consider symptom improvement, side effects, and individual medical needs, as outlined in clinical recommendations for diagnosing and managing ADHD.
The way a medication works depends on the drug. Atomoxetine and viloxazine affect norepinephrine signaling, which supports attention and alertness. Other options, such as guanfacine, act on different receptors involved in attention and impulse regulation.
Non-stimulants are not automatically better or safer for everyone. They can still cause side effects, interact with other medications, and require follow-up appointments. Some may also affect blood pressure, heart rate, sleep, or mood.
A psychiatrist can explain how a particular medication works, what changes to look for, and when to review its effectiveness.
Who May Benefit From a Non-Stimulant Option
Non-stimulant ADHD treatment may be considered when stimulant medication is ineffective, poorly tolerated, or unsuitable for a person’s medical history. It can also be an option for adults who prefer a non-stimulant approach after discussing the benefits and limitations with a psychiatrist.
Adults Managing Anxiety Alongside ADHD
ADHD and anxiety can occur together. An adult may struggle to finish tasks, stay organized, or manage time while also experiencing persistent worry, restlessness, or tension. Because these conditions can share symptoms, a psychiatric evaluation can help determine what contributes to concentration problems. Recognizing the differences between ADHD and anxiety in adults can help clarify which symptoms may be related to each condition.
Medication selection should account for both conditions. Clinicians may consider atomoxetine, viloxazine, or an off-label option such as bupropion, depending on the person’s symptoms and medical history. However, a non-stimulant is not automatically the best choice simply because someone has anxiety. Some adults with ADHD and anxiety can still benefit from stimulant medication.
When both conditions affect daily life, treatment for ADHD and anxiety in adults may involve addressing symptoms of each condition as part of an individualized care plan.
When Stimulant Side Effects Get in the Way
Stimulants can improve ADHD symptoms, but some adults experience side effects that make treatment difficult to continue. These may include reduced appetite, trouble sleeping, irritability, or a faster heart rate.
A psychiatrist may first consider whether changing the dose, timing, or type of stimulant could help. If side effects continue, a non-stimulant ADHD medication may be worth discussing.
The decision should account for the benefits the person experienced, the severity of side effects, and any other medications or health conditions. Plan medication changes with the prescribing psychiatrist rather than making them independently.
Concerns About Misuse or Heart Health
Stimulant medications are controlled substances in the United States because they carry a risk of misuse and diversion. A non-stimulant may be considered when that risk is a concern or when a person’s medical history makes certain stimulant options unsuitable.
Heart health also matters, but non-stimulants still have cardiovascular effects. Atomoxetine and viloxazine can increase blood pressure or heart rate, so monitoring may still be necessary. A history of heart disease, high blood pressure, fainting, or abnormal heart rhythms should be discussed before starting medication.
The safest choice depends on the specific condition and medication. A psychiatrist may review your medical history, current prescriptions, blood pressure, heart rate, and any need for further evaluation before recommending treatment.
FDA-Approved Non-Stimulant ADHD Meds for Adults
Two non-stimulant medications are FDA-approved to treat ADHD in adults in the United States: atomoxetine and viloxazine extended-release. Both are prescription medications, and neither is considered a controlled substance.
Although they both affect norepinephrine signaling, they are not interchangeable. They differ in dosing, potential side effects, drug interactions, and how each person responds.
Atomoxetine (Strattera)
Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor. It affects norepinephrine signaling, which supports attention and impulse control. Its dosing instructions, precautions, possible side effects, and drug interactions are detailed in the prescribing information for atomoxetine capsules.
For adults, atomoxetine may help reduce inattention and other ADHD symptoms throughout the day. It is often considered when stimulant medication has not worked well enough or has caused side effects that are difficult to manage.
Atomoxetine is taken regularly, not just on days when symptoms are more noticeable. Improvement may begin within the first few weeks, but it can take several more weeks to assess the full benefit.
Possible side effects include:
- Nausea or stomach discomfort
- Dry mouth
- Constipation
- Reduced appetite
- Dizziness
- Sleepiness or fatigue
- Sexual side effects or difficulty urinating
Atomoxetine can also raise blood pressure and heart rate. Rarely, it can cause serious liver problems. The prescribing psychiatrist should review other medications and relevant medical history before treatment and monitor for side effects.
Viloxazine (Qelbree)
Viloxazine extended-release, sold as Qelbree, is another FDA-approved option for adults with ADHD. It affects norepinephrine signaling and is taken regularly as part of a treatment plan. The prescribing information for viloxazine extended-release outlines its dosing, warnings, potential side effects, and interactions.
Consider viloxazine when a non-stimulant approach is preferred or when another medication hasn’t provided enough benefit. Its suitability depends on the person’s symptoms, medical history, and other medications.
Potential side effects in adults include:
- Insomnia
- Headache
- Sleepiness or fatigue
- Nausea
- Reduced appetite
- Dry mouth
- Constipation
Viloxazine can increase blood pressure and heart rate. It also carries a warning about an increased risk of suicidal thoughts and behaviors, so new or worsening changes in mood, behavior, or thoughts should be reported promptly. The medication also has important drug interactions, including with certain medications metabolized through CYP1A2.
Before prescribing viloxazine, a psychiatrist should review current medications, relevant medical history, and any history of depression or bipolar disorder. Regular follow-up helps assess both symptom improvement and safety.
Off-Label Options a Psychiatrist May Consider
Some medications are used off-label for ADHD in adults. Off-label prescribing means using a medication for a condition or purpose not included in its FDA-approved indication. Evidence for non-stimulant treatment varies by medication, and research has evaluated the effectiveness and safety of non-stimulant medications for ADHD in adults. A psychiatrist should weigh the available evidence, possible risks, other health conditions, and whether an approved treatment is a better fit.
Options a psychiatrist may consider include:
- Bupropion (Wellbutrin): An antidepressant that affects norepinephrine and dopamine signaling. It may be considered when ADHD occurs alongside depression or when certain other treatment options are unsuitable. It is not FDA-approved for ADHD and may not be appropriate for people with seizure disorders or certain eating disorders.
- Guanfacine: A medication that acts on alpha-2A adrenergic receptors. It is FDA-approved for ADHD in children and adolescents, but adult use is off-label in the United States. It can cause sleepiness, dizziness, low blood pressure, or a slow heart rate.
- Clonidine: Another medication that affects alpha-2 adrenergic receptors. It is sometimes used off-label in ADHD treatment, but evidence and experience in adults are more limited. It may cause sedation and low blood pressure.
These options are not equally supported by research, and their suitability varies. A psychiatrist should consider the evidence for the specific medication, other health conditions, possible interactions, and whether an approved treatment is a better fit.
Do not use another person’s prescription or change an existing medication to treat ADHD without medical guidance.
Stimulant vs Non-Stimulant ADHD Meds
Both medication types can help manage ADHD symptoms, but they differ in how quickly they work, their potential side effects, and how they are prescribed.
| Feature | Stimulant medications | Non-stimulant medications |
|---|---|---|
| Examples | Methylphenidate and amphetamine-based medications | Atomoxetine and viloxazine; some off-label options |
| How they work | Affect dopamine and norepinephrine activity | Mechanism depends on the medication; atomoxetine and viloxazine affect norepinephrine signaling |
| How quickly they work | Often begin working the same day | Usually require regular use over several weeks to assess benefit |
| Duration | Depends on the formulation; some last several hours and others last much of the day | Varies by medication; some provide coverage throughout the day |
| Misuse potential | Some have a risk of misuse and diversion | Atomoxetine and viloxazine are not controlled substances |
| Possible side effects | Reduced appetite, insomnia, irritability, increased heart rate or blood pressure | May include nausea, dry mouth, fatigue, sleep changes, dizziness, or changes in blood pressure and heart rate |
| When considered | Commonly first-line medication options for adults | May be considered when stimulants are ineffective, poorly tolerated, unsuitable, or not preferred after discussing the options |
Neither category is the right choice for every adult. Clinicians often start with stimulants because they work quickly and are effective, but non-stimulants can be useful alternatives. The choice should reflect your symptoms, treatment history, medical needs, and preferences.
How Long Non-Stimulant Meds Take to Work
Non-stimulant ADHD meds generally take longer to show their full effects than stimulant medications. You may notice gradual changes in attention, organization, or impulse control rather than a clear difference after the first dose.
The timeline depends on the medication, dose, and individual response. Atomoxetine may start helping within a few weeks, but it can take longer to assess the full effect. Viloxazine is also taken regularly, with response assessed over time as the dose and tolerability are reviewed.
During the first several weeks, your psychiatrist may ask you to track changes such as:
- How easily you start and finish tasks
- Whether you lose track of conversations or instructions less often
- How well you manage time and daily responsibilities
- Whether side effects affect sleep, appetite, or energy
- Any changes in mood, blood pressure, or heart rate
If the medication doesn’t seem to help, that doesn’t necessarily mean treatment has failed. The psychiatrist may review the dose, how consistently you take it, other factors affecting attention, or whether another treatment would be more appropriate. Do not increase the dose or stop medication without discussing it with the prescriber.
Side Effects to Watch For
Side effects vary by medication, and some may improve as your body adjusts. Others may require a dose change or a different treatment. Tell your psychiatrist about new symptoms, persistent discomfort, or changes that interfere with daily life.
Depending on the medication, side effects may include:
- Digestive symptoms: Nausea, stomach discomfort, or constipation.
- Appetite changes: Reduced hunger or changes in eating habits.
- Sleep changes: Insomnia, sleepiness, or fatigue.
- Dry mouth or dizziness: These can affect comfort and daily activities.
- Blood pressure or heart rate changes: Atomoxetine and viloxazine may increase either, so that monitoring may be needed.
- Mood changes: Report new or worsening depression, agitation, unusual behavior, or suicidal thoughts promptly.
Seek urgent medical care for severe symptoms such as chest pain, fainting, or signs of a serious allergic reaction. If you experience suicidal thoughts or feel unable to stay safe, seek immediate help.
Before starting medication, ask which side effects are most relevant to your prescription, which symptoms require a prompt call, and when to schedule follow-up. Keep your psychiatrist informed about all prescription medicines, over-the-counter products, and supplements you take.
Combining Medication With Other ADHD Treatment
Medication is only one part of managing adult ADHD. Some people benefit from combining medication with therapy, practical supports, and changes to daily routines. Evidence-based recommendations for adult ADHD treatment discuss assessment and management options that can help guide an individualized treatment plan.
Depending on your needs, a treatment plan may include ADHD-focused therapy, organizational strategies, consistent sleep routines, and support for related conditions such as anxiety or depression.
- ADHD-focused therapy: Work on patterns that interfere with daily responsibilities, emotional regulation, or relationships.
- Organizational strategies: Use calendars, reminders, task lists, and routines to reduce what you need to keep in mind.
- Sleep and daily routines: Consistent sleep and regular activity may support attention and energy.
- Support for related conditions: Anxiety, depression, or sleep problems may also affect concentration and should be assessed when appropriate.
Medication is not the only way to work on ADHD-related challenges. Managing ADHD without medication can involve building structured routines, using reminders, and adjusting your environment to support daily functioning. These strategies may complement medication or form part of a treatment plan when medication is not the preferred option.
These strategies do not replace medication when medication is needed, and medication does not automatically resolve every difficulty associated with ADHD. Untreated symptoms can continue to affect work, relationships, and everyday responsibilities, so it is worth discussing the full range of options with a mental health specialist.
Adult ADHD Medication Care in Colleyville & Fort Worth
Choosing a medication can take time, especially if you have tried treatment before or manage other health conditions. A psychiatric evaluation can help clarify your symptoms, review previous medications, and identify options that fit your needs.
Dr. Lisa Fairweather provides psychiatric care in Colleyville and Fort Worth, including ADHD treatment. During an appointment, you can discuss attention and organization difficulties, medication concerns, side effects, and whether a non-stimulant ADHD treatment may be appropriate.
If ADHD symptoms are affecting your work, relationships, or daily responsibilities, schedule an appointment with Dr. Lisa Fairweather to discuss your treatment options.
Sources
- American Academy of Family Physicians. “Attention-Deficit/Hyperactivity Disorder in Adults.” American Family Physician 110, no. 2 (2024): 157–166. https://www.aafp.org/afp/2024/0800/attention-deficit-hyperactivity-disorder-adults.
- National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE Guideline NG87. Published March 14, 2018. Last updated September 13, 2019. https://www.nice.org.uk/guidance/ng87/chapter/Recommendations.
- U.S. Food and Drug Administration. Strattera (Atomoxetine) Capsules: Prescribing Information. Revised 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021411s053lbl.pdf.
- U.S. Food and Drug Administration. Qelbree (Viloxazine Extended-Release Capsules): Prescribing Information. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211964s013lbl.pdf.
- “Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis.” PubMed. Published 2023. https://pubmed.ncbi.nlm.nih.gov/37166701/.
